Current Drug Targets - CNS & Neurological Disorders
Title: Editorial [Hot Topic: Neuron-Glia Interaction (Guest Editor: Joao O. Malva)]
Volume: 4 Issue: 4
Author(s): Joao O. Malva
Affiliation:
Export Options
About this article
Cite this article as:
Malva O. Joao, Editorial [Hot Topic: Neuron-Glia Interaction (Guest Editor: Joao O. Malva)], Current Drug Targets - CNS & Neurological Disorders 2005; 4 (4) . https://dx.doi.org/10.2174/1568007054546135
DOI https://dx.doi.org/10.2174/1568007054546135 |
Print ISSN 1568-007X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-007X |
18
Related Articles
-
Vitamin D Therapy in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design Therapeutic Options in Prevention and Treatment of Aspartoacylase Gene Mutation Resulting Abnormalities in Canavan Disease
Current Pharmacogenomics MMP-9 Inhibitors in the Brain: Can Old Bullets Shoot New Targets?
Current Pharmaceutical Design Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Current Pharmaceutical Design Growth Responses Following a Single Intra-Muscular hGH Plasmid Administration Compared to Daily Injections of hGH in Dwarf Mice
Current Gene Therapy Gene Therapy for Haemophagocytic Lymphohistiocytosis
Current Gene Therapy Clinical Significance of Thiopurine S-Methyltransferase Gene Polymorphisms
Current Pharmacogenomics Clear Cell Renal Cell Cancer Tumor-Propagating Cells: Molecular Characteristics
Current Signal Transduction Therapy Revision of QSAR, Docking, and Molecular Modeling Studies of Anti-Influenza Virus A (H1N1) Drugs and Targets: Analysis of Hemagglutinins 3D Structure
Current Computer-Aided Drug Design The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology Recent Advances in GNAS Epigenetic Research of Pseudohypoparathyroidism
Current Molecular Medicine Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside
Current Pharmaceutical Design Modeling and Simulation Approach to Support Dosing and Study Design Requirements for Treating HIV-Related Neuropsychiatric Disease with the NK1-R Antagonist Aprepitant
Current HIV Research Nanomedicinal Approach of Getting Across the Brood-Brain Barrier with Nanomedicinal Nanoparticles
Current Medicinal Chemistry COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
Current Rheumatology Reviews Neuroinflammation and Immunity: A New Pharmacological Target in Depression
CNS & Neurological Disorders - Drug Targets Advances in Sickle Cell Disease Treatment: from Drug Discovery Until the Patient Monitoring
Cardiovascular & Hematological Agents in Medicinal Chemistry The Long Term Biological Consequences of Anorexia Nervosa
Current Nutrition & Food Science Annexins as Neuroprotective Agents in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents The Protein-Protein Interaction-Mediated Inactivation of PTEN
Current Molecular Medicine